Search
Search Results
- Publication:
- Washington, DC : United States Government Accountability Office, March 2023
- Subject(s):
- Drugs, Generic -- economics
Drug Development -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Patents as Topic -- legislation & jurisprudence
Prescription Fees -- legislation & jurisprudence
United States
- Publication:
- Washington, D.C. : AARP Public Policy Institute, c2010
- Subject(s):
- Drug Costs -- trends
Prescription Drugs -- economics
Drugs, Generic -- economics
Forecasting
Health Care Reform -- economics
Inflation, Economic
Medicare Part D -- economics
Pharmaceutical Preparations -- economics
Humans
United States
- Author(s):
- Purvis, Leigh, author
- Publication:
- Washington, D.C. : AARP Public Policy Institute, September 2014
- Subject(s):
- Biological Products -- economics
Biological Products -- therapeutic use
Biosimilar Pharmaceuticals -- economics
Biosimilar Pharmaceuticals -- therapeutic use
Drug Costs
Drug Substitution
Legislation, Drug
Drugs, Generic -- economics
Federal Government
State Government
Humans
United States
United States. Food and Drug Administration.
United States.
- Author(s):
- Schondelmeyer, Stephen W., author
Purvis, Leigh, author
- Publication:
- Washington, DC : AARP Public Policy Institute, April 2019
- Subject(s):
- Drug Costs -- trends
Drugs, Generic -- economics
Prescription Drugs -- economics
United States
- Author(s):
- Schondelmeyer, Stephen W., author
Purvis, Leigh, author
- Publication:
- Washington, DC : AARP Public Policy Institute, April 2019
- Subject(s):
- Drug Costs -- trends
Drugs, Generic -- economics
Prescription Drugs -- economics
United States
- Author(s):
- Schondelmeyer, Stephen W., author
Purvis, Leigh, author
- Publication:
- Washington, DC : AARP Public Policy Institute, September 2019
- Subject(s):
- Drug Costs -- trends
Drugs, Generic -- economics
Prescription Drugs -- economics
United States
- Author(s):
- Schondelmeyer, Stephen W., author
Purvis, Leigh, author
- Publication:
- Washington, DC : AARP Public Policy Institute, September 2019
- Subject(s):
- Drug Costs -- trends
Drugs, Generic -- economics
Prescription Drugs -- economics
United States
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, May 2022
- Subject(s):
- Drug Industry -- legislation & jurisprudence
Drugs, Generic -- economics
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
- Author(s):
- Sanzenbacher, Geoffrey T., author
Wettstein, Gal, author
- Publication:
- Chestnut Hill, MA : Center for Retirement Research at Boston College, May 2019
- Subject(s):
- Drug Costs
Drugs, Generic -- economics
Medicare Part D -- economics
Patents as Topic
Aged
Drug Industry -- economics
Economics, Pharmaceutical
Humans
United States
United States. Food and Drug Administration.
Medical Expenditure Panel Survey (U.S.)
- Author(s):
- Steiner, David J., author
- Publication:
- [Toronto, Ontario] : Thomson Reuters, 23-December-2019
- Subject(s):
- Drug Costs
Medicare Part D -- economics
Medicare Part D -- legislation & jurisprudence
Biosimilar Pharmaceuticals -- economics
Cost Control -- legislation & jurisprudence
Drugs, Generic -- economics
Economics, Pharmaceutical
Financing, Personal
Fraud
Legislation, Drug
Medicare Part C
Opioid-Related Disorders
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)
